Credit Suisse’s Lineage Cell Therapeutics LCTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-20,900
Closed -$51K 4000
2021
Q4
$51K Buy
+20,900
New +$48.9K ﹤0.01% 4420
2021
Q1
Sell
-15,000
Closed -$26K 4451
2020
Q4
$26K Buy
+15,000
New +$21K ﹤0.01% 4295
2019
Q4
Sell
-27,342
Closed -$27K 4261
2019
Q3
$27K Buy
27,342
+3,759
+16% +$3.89K ﹤0.01% 4076
2019
Q2
$26K Sell
23,583
-4,202
-15% -$4.84K ﹤0.01% 4039
2019
Q1
$36K Buy
27,785
+12,334
+80% +$15.3K ﹤0.01% 3921
2018
Q4
$15K Buy
+15,451
New +$23.7K ﹤0.01% 3841
2018
Q3
Sell
-34,272
Closed -$62K 3897
2018
Q2
$62K Sell
34,272
-12,508
-27% -$25.2K ﹤0.01% 3882
2018
Q1
$110K Buy
46,780
+7,779
+20% +$18.2K ﹤0.01% 3790
2017
Q4
$73K Sell
39,001
-26,246
-40% -$57.3K ﹤0.01% 3879
2017
Q3
$162K Buy
65,247
+42,030
+181% +$104K ﹤0.01% 3988
2017
Q2
$64K Sell
23,217
-920
-4% -$2.57K ﹤0.01% 3761
2017
Q1
$73K Sell
24,137
-18,424
-43% -$52.3K ﹤0.01% 3715
2016
Q4
$134K Buy
42,561
+1,647
+4% +$5.06K ﹤0.01% 3902
2016
Q3
$139K Sell
40,914
-8,109
-17% -$22.4K ﹤0.01% 3878
2016
Q2
$112K Buy
+49,023
New +$120K ﹤0.01% 4035
2016
Q1
Sell
-16,459
Closed -$54K 4159
2015
Q4
$54K Sell
16,459
-1,496
-8% -$4.47K ﹤0.01% 4131
2015
Q3
$43K Sell
17,955
-2,619
-13% -$6.78K ﹤0.01% 4190
2015
Q2
$60K Buy
+20,574
New +$79.8K ﹤0.01% 4447
2015
Q1
Sell
-13,134
Closed -$40K 4482
2014
Q4
$40K Sell
13,134
-1,759
-12% -$4.76K ﹤0.01% 4530
2014
Q3
$37K Sell
14,893
-4,206
-22% -$10.1K ﹤0.01% 4368
2014
Q2
$47K Sell
19,099
-79,757
-81% -$180K ﹤0.01% 4594
2014
Q1
$263K Buy
98,856
+4,716
+5% +$13.9K ﹤0.01% 4184
2013
Q4
$274K Buy
94,140
+64,147
+214% +$194K ﹤0.01% 4136
2013
Q3
$92K Buy
29,993
+13,976
+87% +$44.2K ﹤0.01% 4118
2013
Q2
$51K Buy
+16,017
New +$51.3K ﹤0.01% 4095

Other funds holding LCTX